» Articles » PMID: 23238795

Absence of Inflammatory Conditions in Human Varicose Saphenous Veins

Overview
Journal Inflamm Res
Date 2012 Dec 15
PMID 23238795
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Varicose veins affect one-third of the adult population in western countries, but their pathogenesis is incompletely characterized. One of the most controversial issues is the role of inflammation. It is well known that inflammation involves an increased expression/activity of inflammatory mediators.

Objective: The aim of this study was to investigate the presence or absence of mediators of inflammation in varicose as compared to healthy veins.

Methods And Results: Using immunohistofluorescence on varicose and healthy veins, we investigated the presence of inflammatory cells. They were not detectable. Venous wall C-reactive protein (CRP), fibrinogen (EIA) and pentraxin-3 (Western blot) content were measured. CRP was significantly lower in varicose veins, but no difference was found for fibrinogen or pentraxin-3 between varicose and healthy veins. No difference was observed for enzymes involved in inflammation and responsible for arachidonic acid metabolism such as the acute phase reactant secreted phospholipase A₂-IIA and cyclooxygenase-2, as determined in varicose and healthy veins by Western blot and real-time qRT-PCR.

Conclusions: Our experiments demonstrate no increase in the presence of mediators of inflammation in varicose as compared to healthy veins, suggesting that inflammation may not be an important contributor to the pathogenesis of varicose veins.

Citing Articles

The Impact of Inflammatory Markers and Obesity in Chronic Venous Disease.

Petrascu F, Matei S, Margan M, Ungureanu A, Olteanu G, Murariu M Biomedicines. 2024; 12(11).

PMID: 39595090 PMC: 11592460. DOI: 10.3390/biomedicines12112524.


Utility of routine laboratory tests in the assessment of chronic venous disease progression in female patients.

Matei S, Matei M, Anghel F, Carabenciov E, Murariu M, Olariu S Exp Ther Med. 2022; 24(3):571.

PMID: 35978924 PMC: 9366278. DOI: 10.3892/etm.2022.11508.


Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.

Gomez I, Ozen G, Deschildre C, Amgoud Y, Boubaya L, Gorenne I PLoS One. 2016; 11(6):e0158421.

PMID: 27362269 PMC: 4928935. DOI: 10.1371/journal.pone.0158421.


Decreased PGE₂ content reduces MMP-1 activity and consequently increases collagen density in human varicose vein.

Gomez I, Benyahia C, Louedec L, Leseche G, Jacob M, Longrois D PLoS One. 2014; 9(2):e88021.

PMID: 24505358 PMC: 3914898. DOI: 10.1371/journal.pone.0088021.

References
1.
Manfredi A, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A . Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol. 2008; 20(5):538-44. DOI: 10.1016/j.coi.2008.05.004. View

2.
Schonbeck U, Sukhova G, Graber P, Coulter S, Libby P . Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol. 1999; 155(4):1281-91. PMC: 1867039. DOI: 10.1016/S0002-9440(10)65230-3. View

3.
Fazzini F, Peri G, Doni A, DellAntonio G, Dal Cin E, Bozzolo E . PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum. 2002; 44(12):2841-50. DOI: 10.1002/1529-0131(200112)44:12<2841::aid-art472>3.0.co;2-6. View

4.
Leu H . Inflammatory abdominal aortic aneurysms: a disease entity? Histological analysis of 60 cases of inflammatory aortic aneurysms of unknown aetiology. Virchows Arch A Pathol Anat Histopathol. 1990; 417(5):427-33. DOI: 10.1007/BF01606031. View

5.
Flannagan R, Cosio G, Grinstein S . Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol. 2009; 7(5):355-66. DOI: 10.1038/nrmicro2128. View